If you are pricing out Zepbound, you have probably seen numbers that do not match each other at all: a retail sticker over a thousand dollars a month in one place, and a few hundred dollars in another. Both can be true at the same time, because Zepbound has several different prices depending on how you buy it.
This is a clear 2026 breakdown of what Zepbound (tirzepatide) actually costs: the retail list price, Eli Lilly's lower-cost self-pay vials, what insurance and the savings card change, how the price stacks up against Wegovy and Mounjaro, and where a lower-cost compounded option fits.
The Short Answer
Without insurance, Zepbound lists at roughly $1,086 a month for the prefilled auto-injector pens, at every dose strength. Almost nobody pays that full price.
The two ways most cash-paying patients lower the cost are:
1. LillyDirect Self Pay vials, sold directly by Eli Lilly at roughly $349 to $499 a month depending on the dose. 2. Insurance plus the Zepbound Savings Card, which can bring a covered copay down to as little as $25 a month.
There is also a separate lower-cost route, compounded tirzepatide, covered near the end of this guide.
Zepbound Cost at a Glance
| How you buy it | Approximate 2026 cost per month |
|---|---|
| Retail pens, no insurance | ~$1,086 |
| LillyDirect Self Pay vials (lower doses) | ~$349 to $399 |
| LillyDirect Self Pay vials (higher doses) | ~$449 to $499 |
| Covered by insurance, standard copay | ~$25 to $100 |
| Covered insurance + Zepbound Savings Card | as low as $25 |
| Compounded tirzepatide (telehealth) | varies, often lower than brand pens |
These figures are guides for 2026. Eli Lilly has adjusted its self-pay tiers and savings card terms more than once, so confirm the current number at the point of purchase.
Retail Price: What Zepbound Costs Without Insurance
The Eli Lilly list price for Zepbound is approximately $1,086 a month for a 28-day supply of the single-dose auto-injector pens. Notably, that price is the same across dose strengths, so moving from 5 mg up to 15 mg does not raise the pen list price.
That figure is the starting point that insurers, pharmacy benefit managers, and manufacturer programs negotiate down. It is closest to what an uninsured patient would pay at a pharmacy counter for the pens with no savings program applied, which is exactly why Lilly created lower-cost direct channels.
LillyDirect Self Pay Vials: The Lower Cash Price
To give cash-paying patients a more affordable option, Eli Lilly sells Zepbound as single-dose vials through its LillyDirect Self Pay program, at a meaningfully lower price than the pens.
As a general 2026 guide:
The tradeoff for the lower price is the format. Instead of a prefilled pen that clicks and injects automatically, the vials require you to draw the dose into a syringe yourself and inject it. Many patients are comfortable with this after instruction, but it is a real difference worth knowing before you choose the vial route.
These vials are sold directly to people without insurance (or whose insurance does not cover Zepbound) and are dispensed through Lilly's pharmacy partners. Lilly has changed these price tiers since the program launched, so treat the numbers above as a band rather than a fixed quote.
Zepbound Cost With Insurance
If your plan covers Zepbound, your real cost is a copay set by your formulary tier, commonly $25 to $100 a month. On a high-deductible plan, you may pay closer to the full negotiated price until you meet your deductible, then drop to the copay.
The catch is that coverage for weight-management medication is far from universal. Many commercial plans:
One change worth noting: Zepbound's 2025 FDA approval for moderate-to-severe obstructive sleep apnea in adults with obesity opened coverage on some plans that would otherwise exclude weight-loss use. If you have a qualifying condition, it is worth having your physician note it during the authorization process.
Medicare does not cover medications prescribed solely for weight loss, though it may cover Zepbound when prescribed for an approved condition such as sleep apnea.
### The Zepbound Savings Card
Eli Lilly offers a Zepbound Savings Card for people with commercial insurance (not Medicare or Medicaid):
Savings card terms and caps change periodically, so verify the current offer before you count on a specific dollar figure.
Why Zepbound Has So Many Different Prices
It helps to understand why a single medication can show up at $1,086, $399, and $25 all in the same month. The list price is set by the manufacturer, but it is not a retail price in the normal sense. It is the published number that everyone else negotiates against.
Here is who sits between that list price and what you actually pay:
The practical takeaway: the price you are quoted depends entirely on which of these doors you walk through. Before you accept any single number as "the" cost of Zepbound, it is worth checking all three: your plan's covered copay, the savings card, and the direct self-pay vial price.
A Step-by-Step Way to Find Your Lowest Zepbound Price
Rather than guessing, you can work through the options in order from most to least likely to be cheapest:
1. Check your formulary. Call the member services number on your insurance card or log into your plan portal and search "Zepbound." Confirm whether it is covered, what tier it sits on, and whether prior authorization is required. 2. If covered, apply the savings card. For commercially insured patients whose plan covers Zepbound, the savings card can drop the copay toward $25 a month. 3. If not covered, compare the savings card cap against self-pay vials. For commercially insured patients without coverage, the card has a higher capped amount; the LillyDirect Self Pay vials may be cheaper still. 4. If you have no commercial insurance, look at LillyDirect Self Pay vials directly, at roughly $349 to $499 a month. 5. Then compare against compounded tirzepatide through a licensed, physician-led telehealth provider, covered below.
Working the list in this order keeps you from defaulting to the $1,086 retail pen price, which is almost never the right number for an individual patient.
Zepbound vs Wegovy vs Mounjaro: Cost Comparison
Zepbound is often compared on price with the other major brand-name weight and metabolic medications. Here is how the retail list prices line up in 2026:
| Medication | Active ingredient | FDA-approved use | Retail list (no insurance) |
|---|---|---|---|
| Zepbound | Tirzepatide | Chronic weight management; obstructive sleep apnea | ~$1,086/month |
| Wegovy | Semaglutide | Chronic weight management | ~$1,349/month |
| Mounjaro | Tirzepatide | Type 2 diabetes | ~$1,069/month |
A few things stand out:
For a deeper look at side effects and tolerability that factor into the brand decision, see our guide to Zepbound side effects.
Does the Dose Change the Price?
This is a common point of confusion. For the brand-name pens, the answer is no: the list price is roughly $1,086 a month at every dose strength, from 2.5 mg up to 15 mg. You do not pay more as your physician titrates you up.
For the LillyDirect Self Pay vials, the answer is yes, modestly: the lower starting doses run cheaper (around $349 to $399) and the higher doses run a bit more (around $449 to $499). The difference between the cheapest and most expensive vial tier is roughly $100 to $150 a month.
Most patients start at 2.5 mg as a four-week starter dose, then increase in steps based on response and tolerability, so your monthly cost on the vials may rise somewhat over the first few months before settling at your maintenance dose. With insurance, your copay typically stays flat regardless of dose.
Cost Per Pound of Weight Lost
A useful way to think about value is cost relative to results, not just the monthly price.
In SURMOUNT-1 (NEJM, 2022), the foundational trial for tirzepatide in adults with obesity or overweight without diabetes, participants on the highest dose lost an average of approximately 20.9% of body weight at 72 weeks. Individual results vary, and these are published trial figures, not a promise of any specific outcome.
For perspective, that trial-average percentage on a 220-pound starting weight would represent roughly 46 pounds of average loss over the study period. The point of the framing is simple: a higher monthly price can still translate to a lower cost per pound when the medication produces larger average reductions, which is why the brand decision is clinical, not purely about the sticker number. Your physician is the right person to weigh dose, tolerability, and goals together.
Compounded Tirzepatide: A Lower-Cost Option
Beyond brand-name Zepbound, some telehealth providers offer compounded tirzepatide, prepared by a state-licensed compounding pharmacy under an individual physician prescription. For patients without insurance coverage for the brand, this can be a lower monthly cost than the retail pens.
A few facts to anchor the decision:
*Compounded medications are not FDA-approved as final products. The active pharmaceutical ingredient is FDA-registered.*
The availability and legal status of compounded tirzepatide depend on FDA shortage status and current regulations, which have shifted over the past year. For current pricing and how the compounded route compares, see our breakdown of compounded tirzepatide cost in 2026, and review transparent monthly pricing on our pricing page.
Can You Use an HSA or FSA for Zepbound?
Yes, in most cases. Because Zepbound is a prescription medication, the cost generally qualifies as an eligible expense under a Health Savings Account (HSA) or Flexible Spending Account (FSA). That does not lower the sticker price, but it lets you pay with pre-tax dollars, which effectively reduces the real cost by your marginal tax rate.
A few practical notes:
For patients paying cash, stacking an FSA or HSA on top of the LillyDirect vial price is one of the simplest ways to trim the net monthly cost without changing how you buy the medication.
So, How Much Does Zepbound Really Cost?
Putting it together:
The single most important step is to confirm your own plan's coverage and the current manufacturer program terms, because the same medication can cost one person $25 and another person many times that, depending entirely on how they buy it.
What Majesta Health Offers
At Majesta Health, we provide compounded tirzepatide through licensed, FDA-registered compounding pharmacies, with board-certified physician oversight and transparent monthly pricing. Compounded medications are not FDA-approved as final products. The active pharmaceutical ingredient is FDA-registered.
This article is general information, not medical advice. A licensed physician reviews your history before prescribing and is the right person to help you weigh cost, coverage, and the best option for your situation. Start your 2-minute medical assessment at /quiz to see if you qualify.
Frequently Asked Questions
How much does Zepbound cost without insurance in 2026?
Without insurance, Zepbound (tirzepatide) carries a retail list price of roughly $1,086 a month for the auto-injector pens at every dose strength. Very few people pay that full sticker price. Through LillyDirect Self Pay, Eli Lilly sells lower-cost single-dose vials directly to cash-paying patients, with prices that run roughly $349 to $499 a month depending on the dose. The vials require you to draw and inject the medication yourself rather than using a prefilled pen, which is the tradeoff for the lower price.
What is the LillyDirect Self Pay price for Zepbound?
LillyDirect Self Pay offers Zepbound as single-dose vials at a lower price than the retail pens. As a general guide, the lower starting doses (2.5 mg and 5 mg) have been priced around $349 to $399 for a month supply, and the higher doses (7.5 mg and above) around $449 to $499. Lilly has adjusted these tiers over time, so confirm the current price at the point of purchase. The vials are sold directly to cash-paying patients without insurance and are filled through Lilly's pharmacy partners.
Does insurance cover Zepbound?
Coverage varies widely. Zepbound is FDA-approved for chronic weight management and, in 2025, for moderate-to-severe obstructive sleep apnea in adults with obesity, which has expanded coverage for some plans. Many commercial plans still exclude weight-loss medications or require prior authorization documenting BMI criteria and prior attempts at lifestyle change. Medicare does not cover medications prescribed solely for weight loss, though it may cover Zepbound for an approved condition such as sleep apnea. Check your specific formulary, since two people with the same employer can have different coverage.
How much does Zepbound cost with insurance?
If your plan covers Zepbound, your out-of-pocket cost is a copay set by your formulary tier, commonly $25 to $100 a month, and sometimes more on high-deductible plans before the deductible is met. Eli Lilly also offers a Zepbound Savings Card for people with commercial insurance. For patients whose plan covers Zepbound, the card can lower the copay to as little as $25 a month. For commercially insured patients whose plan does not cover Zepbound, the savings card historically reduced the cost to a higher capped amount. Terms change, so verify current card details before relying on a specific number.
How does Zepbound cost compare to Wegovy and Mounjaro?
At retail without insurance, Zepbound lists around $1,086 a month, Wegovy around $1,349 a month, and Mounjaro (the diabetes-labeled version of tirzepatide) around $1,069 a month. Zepbound and Mounjaro contain the same active ingredient, tirzepatide, but are labeled and priced for different uses. Self-pay and savings programs change the real-world cost for all three. The brand you are prescribed depends on your diagnosis, your insurance, and your physician's clinical judgment rather than price alone.
Is there a cheaper alternative to Zepbound?
The lowest-cost brand-name route for most cash-paying patients is LillyDirect Self Pay vials, which run roughly $349 to $499 a month. A separate option is compounded tirzepatide, prepared by a state-licensed compounding pharmacy under an individual physician prescription, which some telehealth providers offer at a lower monthly price. Compounded medications are not FDA-approved as final products. The active pharmaceutical ingredient is FDA-registered. Which option is right depends on your insurance, your clinical history, and your physician's judgment.
Why is Zepbound so expensive?
Zepbound is a branded, patent-protected biologic-style peptide medication from Eli Lilly, and its retail price reflects research, manufacturing, and the US pricing environment for new weight-management drugs. The list price is also a starting point that pharmacy benefit managers, insurers, and manufacturer programs negotiate down. That gap between the roughly $1,086 list price and the much lower self-pay and copay prices is why almost no one actually pays the full retail figure.
All Majesta Health medical content is clinically reviewed before publication by US-licensed physicians affiliated with our clinical infrastructure partner, MD Integrations (MDI). Reviewers hold active state medical licenses, are board-certified in primary care or obesity medicine, and specialize in GLP-1 receptor agonist therapy for chronic weight management. MDI is LegitScript certified and SOC 2 Type II accredited.
- US-licensed physicians affiliated with our clinical partner MD Integrations (LegitScript certified, HIPAA, SOC 2 Type II, ISO certified)
- Board-certified in primary care and obesity medicine
- Active state medical licensure required for every prescribing clinician
- Active DEA registration where applicable (note: GLP-1 medications are not controlled substances)
- Telehealth practice across all 50 US states and DC through the MD Integrations Medical Services Organization
- Dispensing pharmacy partner: Belmar Pharma Solutions (LegitScript certified, NABP accredited, 503A and 503B compounding)